Structure-Based Design of Inhibitors of Protein–Protein Interactions: Mimicking Peptide Binding Epitopes
Protein–protein interactions (PPIs) are involved at all levels of cellular organization, thus making the development of PPI inhibitors extremely valuable. The identification of selective inhibitors is challenging because of the shallow and extended nature of PPI interfaces. Inhibitors can be obtaine...
Main Authors: | , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
WILEY-VCH Verlag
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557054/ |
id |
pubmed-4557054 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-45570542015-09-08 Structure-Based Design of Inhibitors of Protein–Protein Interactions: Mimicking Peptide Binding Epitopes Pelay-Gimeno, Marta Glas, Adrian Koch, Oliver Grossmann, Tom N Review Protein–protein interactions (PPIs) are involved at all levels of cellular organization, thus making the development of PPI inhibitors extremely valuable. The identification of selective inhibitors is challenging because of the shallow and extended nature of PPI interfaces. Inhibitors can be obtained by mimicking peptide binding epitopes in their bioactive conformation. For this purpose, several strategies have been evolved to enable a projection of side chain functionalities in analogy to peptide secondary structures, thereby yielding molecules that are generally referred to as peptidomimetics. Herein, we introduce a new classification of peptidomimetics (classes A–D) that enables a clear assignment of available approaches. Based on this classification, the Review summarizes strategies that have been applied for the structure-based design of PPI inhibitors through stabilizing or mimicking turns, β-sheets, and helices. WILEY-VCH Verlag 2015-07-27 2015-06-26 /pmc/articles/PMC4557054/ /pubmed/26119925 http://dx.doi.org/10.1002/anie.201412070 Text en © 2015 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Pelay-Gimeno, Marta Glas, Adrian Koch, Oliver Grossmann, Tom N |
spellingShingle |
Pelay-Gimeno, Marta Glas, Adrian Koch, Oliver Grossmann, Tom N Structure-Based Design of Inhibitors of Protein–Protein Interactions: Mimicking Peptide Binding Epitopes |
author_facet |
Pelay-Gimeno, Marta Glas, Adrian Koch, Oliver Grossmann, Tom N |
author_sort |
Pelay-Gimeno, Marta |
title |
Structure-Based Design of Inhibitors of Protein–Protein Interactions: Mimicking Peptide Binding Epitopes |
title_short |
Structure-Based Design of Inhibitors of Protein–Protein Interactions: Mimicking Peptide Binding Epitopes |
title_full |
Structure-Based Design of Inhibitors of Protein–Protein Interactions: Mimicking Peptide Binding Epitopes |
title_fullStr |
Structure-Based Design of Inhibitors of Protein–Protein Interactions: Mimicking Peptide Binding Epitopes |
title_full_unstemmed |
Structure-Based Design of Inhibitors of Protein–Protein Interactions: Mimicking Peptide Binding Epitopes |
title_sort |
structure-based design of inhibitors of protein–protein interactions: mimicking peptide binding epitopes |
description |
Protein–protein interactions (PPIs) are involved at all levels of cellular organization, thus making the development of PPI inhibitors extremely valuable. The identification of selective inhibitors is challenging because of the shallow and extended nature of PPI interfaces. Inhibitors can be obtained by mimicking peptide binding epitopes in their bioactive conformation. For this purpose, several strategies have been evolved to enable a projection of side chain functionalities in analogy to peptide secondary structures, thereby yielding molecules that are generally referred to as peptidomimetics. Herein, we introduce a new classification of peptidomimetics (classes A–D) that enables a clear assignment of available approaches. Based on this classification, the Review summarizes strategies that have been applied for the structure-based design of PPI inhibitors through stabilizing or mimicking turns, β-sheets, and helices. |
publisher |
WILEY-VCH Verlag |
publishDate |
2015 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557054/ |
_version_ |
1613471788862275584 |